Document:

Exhibit 10.1

Exhibit 10.1 

EMPLOYMENT AGREEMENT 

        THIS
EMPLOYMENT AGREEMENT (this “Agreement”) is entered into as of November 1,
2005 between Bactolac Pharmaceutical, Inc. Inc., a Delaware corporation (the “Company”)
and Pailla Reddy (the “Executive”).  

RECITALS 

         
    A.       
          This Agreement is entered into following a previous employment agreement dated
          as of November 17, 1999 and subsequent extensions of that employment agreement.
          The Company is a wholly owned subsidiary of Advanced Nutraceuticals, Inc.,
          (“ANI”). 

         
    B.       
          The Company desires to continue to employ the Executive, and the Executive
          desires to continue to be so employed by the Company, on the terms and subject
          to the conditions set forth in this Agreement. 

AGREEMENT 

        NOW,
THEREFORE, in consideration of the premises and the mutual promises set forth in this
Agreement, the Company and the Executive hereby agree as follows:  

         
    1.       
          Employment. 

         
            (a)       
          Subject to the terms and conditions contained herein, the Company employs the
          Executive, and the Executive accepts such employment, from the date hereof until
          the earlier of (i) November 1, 2007 or (ii) the date such employment is
          terminated pursuant to Section 4 of this Agreement. During the Executive’s
          employment under this Agreement, the Executive shall perform such duties for the
          Company as may from time to time be assigned to the Executive by the Board of
          Directors of the Company (the “Board”). The Executive shall have the
          title of President and such additional titles as from time to time may be
          assigned to the Executive by the Board. 

         
            (b)       
          The Executive will devote substantial business time, energy, attention and skill
          to the services of the Company and its affiliates and to the promotion of their
          interests; provided, however, the Executive may render services to Invagen
          Pharmaceuticals, Inc., Shilpa-Saketh Realty, (or other part-time real estate
          ventures), or any business that does not compete with the Company in the vitamin
          and nutraceutical industry, none which will interfere in any material respect
          with his duties to the Company. So long as the Executive is employed by the
          Company, the Executive shall not, without the written consent of the Company: 

         
            
            (i)       
          engage in any other significant activity for compensation, profit or other
          pecuniary advantage, whether received during or after the term of this
          Agreement; 

         
            
            (ii)       
          render or perform other significant services of a business, professional, or
          commercial nature other than to or for the Company, either alone or as an
          employee, consultant, director, officer, or partner of another business entity,
          whether or not for compensation, and whether or not such activity, occupation or
          endeavor is similar to, competitive with, or adverse to the business or welfare
          of the Company, (the Executive may from time to time consult with Atlantic
          Essentials (“AE”) regarding certain of AE’s business operations);
          or 

         
            
            (iii)       
          invest in or become a shareholder of another corporation or other entity;
          provided, that the Executive’s investment solely as a shareholder in
          another corporation shall not be prohibited hereby so long as such investment is
          not in excess of four point nine percent (4.9%) of any class of shares that are
          traded on a national securities exchange or quoted on the NASDAQ National
          Market; and, provided further, Executive may maintain his ownership interest in
          Invagen Pharmaceuticals, Inc, a company in the business of pharmaceuticals which
          Executive represents is not in, nor will it enter, the business of manufacturing
          nutritional supplements, and any other ownership holdings of Executive as of the
          date of this Agreement. 

         
    2.       
          Location of Employment. The Executive’s principal place of
          employment shall be at the executive offices of the Company located in
          Hauppauge, New York or in the same general area; provided, that at the direction
          of the Board, the Executive may from time to time be required to travel to
          various domestic and foreign locations. 

         
    3.       
          Compensation. 

         
            (a)       
          In exchange for full performance of the Executive’s obligations and duties
          under this Agreement, the Company shall pay the Executive a base salary at a
          monthly rate of $29,666.67, payable in accordance with the Company’s
          standard payroll practices. The base salary described in subsection (a) hereof
          is a gross amount, and the Company shall be required to withhold from such
          amount deductions with respect to Federal, state and local taxes, FICA,
          unemployment compensation taxes and similar taxes, assessments or withholding
          requirements. 

         
            (b)       
          In addition to the base salary, Executive shall be entitled to a performance
          bonus (the “Bonus”) at the discretion of the Board. 

         
            (c)       
          During the Executive’s employment under this Agreement, the Executive shall
          also be reimbursed by the Company for reasonable business expenses actually
          incurred or paid by the Executive, consistent with the policies established by
          the Board, in rendering to the Company the services provided for in this
          Agreement, upon presentation of expense statements or such other supporting
          information as is consistent with the policies of the Company. 

         
            (d)       
          The Executive shall be entitled to 15 business days vacation for each full year
          of employment under this Agreement, which vacation time will accrue in
          accordance with the vacation policy of the Company. 

         
            (e)       
          The Executive shall be entitled to participate in all benefit plans (including
          deferred compensation plans and any medical, dental or life insurance plans)
          which shall be available from time to time to the domestic management employees
          of the Company generally, except to the extent such participation in any plan
          would alter the intended tax treatment of such plan; provided, however, that the
          Executive shall have no right under this Agreement to participate in any
          additional stock option, stock purchase or other plan relating to shares of
          capital stock of the Company or its affiliates. The Executive acknowledges and
          agrees that the Board may in its discretion terminate at any time or modify from
          time to time any such benefit plans. 

-2- 

         
            (f)       
          The Executive shall be provided the use of a Company paid automobile of a
          similar model to those previously provided to Executive by the Company. 

         
    4.       
          Termination. 

         
            (a)       
          The employment of the Executive under this Agreement may be terminated by the
          Company immediately upon giving the Executive notice if the Executive has been
          unable to discharge his essential job duties by reason of illness or injury for
          either (A) a period of one hundred twenty (120) consecutive days or (B) one
          hundred eighty (180) days in any twelve month period. In the event of any
          dispute regarding the existence of Executive’s Disability hereunder, the
          matter will be resolved by the determination of a majority of three physicians
          qualified to practice medicine in New York, one to be selected by each of
          Executive and the Board and the third to be selected by the two designated
          physicians. For this purpose, Executive will submit to appropriate medical
          examinations. 

         
            (b)       
          The employment of the Executive under this Agreement shall terminate on the date
          of the Executive’s death. 

         
            (c)       
          The employment of the Executive under this Agreement may be terminated by the
          Company for Cause. For purposes of this Agreement, “Cause” shall mean
          (i) the willful failure or refusal by the Executive to perform his duties
          hereunder which has not ceased within ten (10) business days after written
          demand for substantial performance is delivered to the Executive by the Company,
          which demand identifies the manner in which the Company believes that the
          Executive has not performed such duties; (ii) the Executive shall intentionally
          engage in misconduct toward the Company which is materially injurious to the
          Company, ANI, or its Subsidiaries, monetarily or otherwise or (iii) the
          conviction of the Executive of or the entering of a plea of nolo
          contendre by the Executive with respect to, a felony or a crime involving
          moral turpitude. 

         
            (d)       
          The employment of the Executive under this Agreement shall terminate upon
          receipt by the Board of a written notice of resignation signed by the Executive.
          Such notice shall provide a minimum of four months notice prior to the date of
          termination by Executive. 

         
            (e)       
          In addition to the circumstances described in subsections (a), (b), (c) and (d)
          above, the Company may terminate the Executive’s employment for any reason
          or no reason and with or without cause or prior notice. 

         
            (f)       
          If the Executive’s employment is terminated pursuant to this Section 4 or
          for any other reason, the Executive shall not be entitled to any compensation or
          benefits from the Company, under Section 3 of this Agreement or otherwise,
          except for the following: 

-3- 

         
            
            (i)       
          base salary and vacation pay accrued, and reasonable business expenses incurred,
          under Section 3 of this Agreement through the date of such termination; 

         
            
            (ii)       
          such benefits, if any, as may be required to be provided by the Company under the Comprehensive Omnibus
Budget Reconciliation Act (COBRA); and 

         
            
            (iii)       
          if the Executive’s employment is terminated pursuant to subsection (e)
          above, the Company shall continue to pay to the Executive the base salary
          described in Section 3(a) above until the earlier of (A) twelve (12) months
          following such termination or (B) the termination date set forth in Section
          1(a)(i) of this Agreement. 

         
            (g)       
          Executive may terminate his employment hereunder for “Good Reason” (as
          hereinafter defined). 

         
            
            (i)       
          For purposes of this Agreement, “Good Reason” shall mean: (A) a
          reduction in Executive’s base salary then in effect; (B) a material
          reduction in Executive’s positions, duties and responsibilities from those
          described in Section 1(a) of this Agreement; or (C) the failure of the Company
          to obtain the assumption of this Agreement by any successor to the extent
          required pursuant to Section 12(a) of this Agreement. 

         
                        
(ii)       
          Notwithstanding the foregoing, a termination shall not be treated as a
          termination for Good Reason (A) if Executive shall have specifically consented
          in writing to the occurrence of the event giving rise to the claim of
          termination for Good Reason or (B) unless Executive, within thirty (30) days
          after receiving written notice from the Company specifying in reasonable detail
          the occurrence of one of such events, shall have delivered a written notice to
          the Company stating that he intends to terminate his employment for Good Reason
          and specifying the factual basis for such termination and such event, if capable
          of being cured, shall not have been cured within thirty (30) days of the receipt
          by the Company of such notice. 

         
            
            (iii)       
          If Executive shall terminate his employment for Good Reason pursuant to this
          subsection (g), the Company shall pay Executive (or, in the event of his death,
          his devisee, legatee or, if there is none, his estate) a lump-sum amount equal
          to the lesser of (A) the Executive’s monthly base salary in effect on the
          date of termination, multiplied by a factor twelve (12), or (B) the
          Executive’s monthly base salary in effect on the date of termination,
          multiplied by the number of months remaining until the termination date set
          forth in Section 1(a)(i) of this Agreement. Executive will also be entitled to
          any vested benefits under any employee benefit plans. 

         
            (h)       
          As a condition to and in consideration of the payments under subsections (f) and
          (g) hereof, the Executive shall execute a general release as to both known and
          unknown matters occurring prior to the date of termination. 

         
    5.       
          Executive’s Representations. 

         
            (a)       
          The Executive represents that he has full authority to enter into this Agreement
          and that he is free to enter into this Agreement and not under any contractual
          restraint which would prohibit the Executive from satisfactorily performing his
          duties to the Company under this Agreement. 

-4- 

         
            (b)       
          The Executive hereby agrees to indemnify and hold harmless the Company, its
          officers, directors and stockholders from and against any losses, liabilities,
          damages or costs (including reasonable attorney’s fees) arising out of a
          breach, or claimed breach, of any of the representations, warranties and
          covenants of the Executive set forth in this Agreement. 

         
            (c)       
          The Executive acknowledges that he is free to seek advice from independent
          counsel with respect to this Agreement. The Executive has either obtained such
          advice or, after carefully reviewing this Agreement, has decided to forego such
          advice. The Executive is not relying on any representation or advice from the
          Company or any of its officers, directors, attorneys or other representatives
          regarding this Agreement, its content or effect. 

         
    6.       
          Confidentiality; Non-Solicitation. 

         
            (a)       
          Disclosure. The Executive acknowledges that, in the performance of duties
          on behalf of the Company, the Executive shall have access to, receive and be
          entrusted with confidential information, including but in no way limited to
          development, marketing, organizational, financial, management, administrative,
          production, distribution and sales information, data, specifications and
          processes presently owned or at any time in the future developed by, the Company
          or its agents or consultants, or used presently or at any time in the future in
          the course of its business that is not otherwise part of the public domain
          (collectively, the “Confidential Material”). All such Confidential
          Material is considered secret and will be available to the Executive in
          confidence. Except in the performance of the Executive’s duties on behalf
          of the Company, the Executive shall not, directly or indirectly for any reason
          whatsoever, disclose or use any such Confidential Material, unless such
          Confidential Material ceases (through no fault of Executive’s) to be
          confidential because it has become part of the public domain. All records,
          files, drawings, documents, equipment and other tangible items, wherever
          located, relating in any way to the Confidential Material or otherwise to the
          Company’s business, which the Executive prepares, uses, or encounters,
          shall be and remain the Company’s sole and exclusive property and shall be
          included in the Confidential Material. Upon termination of this Agreement by any
          means, or whenever requested by the Company, the Executive shall promptly
          deliver to the Company any and all of the Confidential Material not previously
          delivered to the Company that may be or at any previous time has been in the
          Executive’s possession or under the Executive’s control. 

         
            (b)       
          Unfair Competition. The Executive hereby acknowledges that the sale or
          unauthorized use or disclosure of any of the Company’s Confidential
          Material by Executive by any means whatsoever at any time before, during or
          after the Executive’s employment with the Company shall constitute
          “Unfair Competition.” The Executive agrees that the Executive shall
          not engage in Unfair Competition either during the time the Executive is
          employed by the Company or at any time thereafter. 

-5- 

         
            (c)       
          Other. In the event of the termination of the Executive’s employment
          for any reason, the Executive (and any corporation or entity of which the
          Executive is a director, officer, employee or greater than ten percent (10%)
          shareholder) shall not, directly or indirectly, for a period equal to the
          termination pay period paid to Executive under Section 4 above: 

         
            
            (i)       
          solicit for employment and/or employ any employee, consultant, agent or
          representative (an “employee”) of the Company or any of its affiliates
          or subsidiaries (or any such employee who has been “employed” by the
          Company during the six (6) month period prior to the termination of this
          Agreement) or induce or attempt to induce any customer, supplier, licensee or
          other business relation of the Company or any of its affiliates or subsidiaries
          to cease doing business with the Company or such affiliate or subsidiary or
          interfere in any way with the relationship between any such customer, supplier,
          licensee or business relation and the Company or any affiliate or subsidiary; or 

         
            
            (ii)       
          make any public statement concerning the Company, any of its affiliates or
          subsidiaries, or the Executive’s employment unless previously approved by
          the Company, except as may be required by law. 

         
            (d)       
          In the event of the breach or a threatened breach by the Executive of any of the
          provisions of this Section 6, the Company, in addition and supplementary to
          other rights and remedies existing in its favor, may apply to any court of law
          or equity of competent jurisdiction for specific performance and/or injunctive
          or other relief in order to enforce or prevent any violations of the provisions
          thereof (without posting a bond or other security). 

         
            (e)       
          Upon termination of this Agreement, the Executive shall be deemed to have
          resigned from all offices and directorships then held with the Company or any
          affiliate entity. 

         
    7.       
          Arbitration. Any controversy or claim arising out of or relating to this
          Agreement or any breach hereof or the Executive’s employment by the Company
          or termination thereof, shall be settled by arbitration (other than injunctive
          relief) by one arbitrator in accordance with the rules of the American
          Arbitration Association, and judgment upon such award rendered by the arbitrator
          may be entered in any court having jurisdiction thereof. The arbitration shall
          be held in New York, New York or such other place as may be agreed upon at the
          time by the parties to the arbitration. 

         
    8.       
          Mitigation of Damages. In the event of any termination of the
          Executive’s employment by the Company, the Executive shall not be required
          to seek other employment to mitigate damages. 

         
    9.       
          Equitable Relief. The Executive acknowledges that the Company is relying
          for its protection upon the existence and validity of the provisions of this
          Agreement, that the services to be rendered by the Executive are of a special,
          unique and extraordinary character, and that irreparable injury will result to
          the Company from any violation or continuing violation of the provisions of this
          Agreement for which damages may not be an adequate remedy. Accordingly, the
          Executive hereby agrees that in addition to the remedies available to the
          Company by law or under this Agreement, the Company shall be entitled to obtain
          such equitable relief (without bond) as may be permitted by law in a court of
          competent jurisdiction including, without limitation, injunctive relief from any
          violation or continuing violation by the Executive of any term or provision of
          this Agreement. In the event of an action pursuant to this Agreement, the
          prevailing party shall be entitled to its costs and expenses, including
          reasonable attorneys’ fees. 

-6- 

         
    10.       
          Governing Law. This Agreement shall be governed by and construed and
          enforced in accordance with the internal substantive laws (and not the laws of
          conflicts) of the State of Delaware. 

         
    11.       
          Entire Agreement. This Agreement constitutes the whole agreement of the
          parties hereto in reference to any employment of the Executive by the Company
          and in reference to any of the matters or things herein provided for or
          hereinabove discussed or mentioned in reference to such employment; all prior
          agreements, promises, representations and understandings relative thereto being
          herein merged. 

         
    12.       
          Assignability. 

         
            (a)       
          In the event the Company or its parent ANI, shall merge or consolidate with any
          other corporation, partnership or business entity, or all or substantially all
          of the Company’s business or assets shall be transferred in any manner to
          any other corporation, partnership or business entity, then such successor to
          the Company shall thereupon succeed to, and be subject to, all rights,
          interests, duties and obligations of, and shall thereafter be deemed for all
          purposes hereof to be, the “Company” under this Agreement. This
          Agreement shall inure to the benefit of and be enforceable by Executive’s
          personal or legal representatives, executors, administrators, successors, heirs,
          distributees, devisees and legatees. If Executive should die, any amounts
          payable to him hereunder shall be paid in accordance with the terms of this
          Agreement to Executive’s devisee, legatee, or other designee or, if there
          be no such designee, to his estate. 

         
            (b)       
          This Agreement is personal in nature and the Executive shall not, without the
          written consent of the Company, assign or transfer this Agreement or any rights
          or obligations hereunder. 

         
            (c)       
          Except as set forth in subsection (a) above, nothing expressed or implied in
          this Agreement is intended or shall be construed to confer upon or give to any
          person, other than the parties to this Agreement, any right, remedy or claim
          under or by reason of this Agreement or of any term, covenant or condition of
          this Agreement. 

         
    13.       
          Amendments; Waivers. This Agreement may be amended, modified, superseded,
          canceled, renewed or extended and the terms or covenants of this Agreement may
          be waived only by a written instrument executed by the parties to this Agreement
          or, in the case of a waiver, by the party waiving compliance. Any such written
          instrument must be approved by the Board to be effective as against the Company.
          The failure of any party at any time or times to require performance of any
          provision of this Agreement shall in no manner affect the right at a later time
          to enforce the same. No waiver by any party of the breach of any term or
          provision contained in this Agreement, whether by conduct or otherwise, in any
          one or more instances, shall be deemed to be, or construed as, a further or
          continuing waiver of any such breach, or a waiver of the breach of any other
          term or covenant contained in this Agreement. 

-7- 

         
    14.       
          Notice. All notices, requests or consents required or permitted under
          this Agreement shall be made in writing and shall be given to the other parties
          by personal delivery, overnight air courier (with receipt signature) or
          facsimile transmission (with “answerback” confirmation of
          transmission), sent to such parties’ addresses or telecopy numbers as are
          set forth below such parties’ signatures to this Agreement, or such other
          addresses or telecopy numbers of which the parties have given notice pursuant to
          this Section 14. Each such notice, request or consent shall be deemed effective
          upon the date of actual receipt, receipt signature or confirmation of
          transmission, as applicable. 

         
    15.       
          Severability. Any provision of this Agreement that is prohibited or
          unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective
          to the extent of such prohibition or unenforceability without invalidating the
          remaining provisions hereof, and any such prohibition or unenforceability in any
          jurisdiction shall not invalidate or render unenforceable such provision in any
          other jurisdiction. 

         
    16.       
          Survival. The representations and agreements of the parties set forth in
          Sections 5, 6, 7, 8 and 9 of this Agreement shall survive the expiration or
          termination of this Agreement (irrespective of the reason for such expiration or
          termination). 

[SIGNATURE PAGES FOLLOW] 

-8- 

        IN
WITNESS WHEREOF, the parties to this Agreement have executed this Employment Agreement as
of the date first above written.  

		
		BACTOLAC PHARMACEUTICAL INC.,

a Delaware corporation

By:   /s/ Jeffrey G. McGonegal   

    Name: Jeffrey G. McGonegal

    Title: Senior Vice President - Finance

Address for Notices:

7 Oser Avenue

Hauppauge, New York 11788

Facsimile: (631) 951-4749

Attention: Senior Vice President - Finance

Agreement acknowledged by:

ADVANCED NUTRACEUTICALS, INC.,

a Texas corporation

By:    /s/ Jeffrey G. McGonegal    

    Name: Jeffrey G. McGonegal

    Title: Senior Vice President - Finance

Address for Notices:

106 S. University Blvd., #14

Denver, Colorado 80209

Facsimile: (303) 722-4011

Attention: President

with a copy to:

Brownstein Hyatt & Farber, P. C.

410 Seventeenth Street, 22nd Floor

Denver, Colorado 80202-4437

Facsimile: (303) 223-0934

Attention: Adam Agron
 

-9- 

		
		
  /s/ Pailla Reddy  

Pailla Reddy

Address for Notices

7 Oser Avenue

Hauppauge, New York 11788

Facsimile: (631) 951-4749

with a copy to:

Anthony T. Scotto, Esq.

401 Franklin Avenue

Garden City, New York 11530

Facsimile: (516) 739-5451
 

-10-Exhibit 10.1

                        SECURITIES PURCHASE AGREEMENT

THIS SECURITIES PURCHASE AGREEMENT (this "Agreement"), dated as of November 16,
2005, by and among POP N GO INC., a Delaware corporation (the "Company"), and
the Buyer listed on Schedule I attached hereto (the "Buyer").

                                   WITNESSETH

WHEREAS, the Company and the Buyer are executing and delivering this Agreement
in reliance upon an exemption from securities registration pursuant to Section
4(2) and/or Rule 506 of Regulation D ("Regulation D") as promulgated by the U.S.
Securities and Exchange Commission (the "SEC") under the Securities Act of 1933,
as amended (the "Securities Act");

WHEREAS, the Buyer has purchased from the Company the following securities: (i)
a May 17, 2004, 5% convertible debenture in the original principal amount of
$70,000, (ii) a July 22, 2004, 5% convertible debenture in the original
principal amount of $70,000, (iii) a September 13, 2004, 5% convertible
debenture in the original principal amount of $60,000, and (iv) a November 24,
2004, 12% promissory note in the original principal amount of $150,000
(collectively referred to as the "Prior Securities").  On February 9, 2005 the
Prior Securities were surrendered to the Company and converted into a single 12%
promissory note in the principal amount of $350,000 (the "February 2005 Note")
which represented the entire original principal amount of the Prior Securities.

WHEREAS, as of the date hereof, the Buyer is the beneficial owner of the
February 2005 Note.  The Buyer desires to surrender the February 2005 Note plus
accrued and unpaid interest on the February 2005 Note through the date hereof
($350,000 in principal plus $41,057 as and for interest on the February 2005
Note, for a total of 391,057) for conversion into the convertible debentures and
to purchase additional convertible debentures as outlined below for the total
purchase price of One Million Two Hundred Thousand Dollars ($1,200,000);

WHEREAS, the parties desire that, upon the terms and subject to the conditions
contained herein, the Company shall issue and sell to the Buyer, as provided
herein, and the Buyer shall purchase up to One Million Two Hundred Thousand
Dollars ($1,200,000) of secured convertible debentures (the "Convertible
Debentures"), which shall be convertible into shares of the Company's common
stock, par value $0.001 (the "Common Stock") (as converted, the "Conversion
Shares") of which  Three Hundred Ninety One Thousand Fifty Seven Dollars
($391,057) shall be purchased for consideration solely consisting of
surrendering the February 2005 Note, and Three Hundred Eight Thousand Nine
Hundred Forty Three Dollars ($308,943) shall be purchased by additional funding
by the Buyer for a total of Seven Hundred Thousand Dollars ($700,000) within
five (5) business days following the date hereof (the "First Closing"), and Five
Hundred Thousand Dollars ($500,000) shall be purchased by the Buyer within five
(5) business following the date the Company effectuates an increase its
authorized capital stock (the "Second Closing") (individually referred to as a
"Closing" collectively referred to as the "Closings"), for a total purchase
price of up to One Million Two Hundred Thousand Dollars ($1,200,000) (the
"Purchase Price"); and

WHEREAS, contemporaneously with the execution and delivery of this Agreement,
the parties hereto are executing and delivering a Registration Rights Agreement
(the "Investor Registration Rights Agreement") pursuant to which the Company has
agreed to provide certain registration rights under the Securities Act and the
rules and regulations promulgated there under, and applicable state securities
laws; and

WHEREAS, the aggregate proceeds of the sale of the Convertible Debentures
contemplated hereby shall be held in escrow pursuant to the terms of an escrow
agreement (the "Escrow Agreement") between the Company, the Buyer, and David
Gonzalez, Esq. (the "Escrow Agent").

WHEREAS, contemporaneously with the execution and delivery of this Agreement,
the parties hereto are executing and delivering an Amended and Restated Security
Agreement (the "Security Agreement") pursuant to which the Company has agreed to
provide the Buyer a security interest in Pledged Collateral (as this term is
defined in the Security Agreement) to secure the Company's obligations under
this Agreement, the Transaction Documents, or any other obligations of the
Company to the Buyer; and

WHEREAS, contemporaneously with the execution and delivery of this Agreement,
the parties hereto are executing and delivering Irrevocable Transfer Agent
Instructions (the "Irrevocable Transfer Agent Instructions").

NOW, THEREFORE, in consideration of the mutual covenants and other agreements
     contained in this Agreement the Company and the Buyer hereby agree as
     follows: 1.	PURCHASE AND SALE OF CONVERTIBLE DEBENTURES.

        (a)	Purchase of Convertible Debentures.  Subject to the satisfaction
(or waiver) of the terms and conditions of this Agreement, the Buyer agrees to
purchase at each Closing and the Company agrees to sell and issue to each Buyer
at each Closing, Convertible Debentures in amounts corresponding with the
Subscription Amount set forth opposite the Buyer's name on Schedule I hereto.
Upon execution hereof by a Buyer, the Buyer shall wire transfer the cash portion
of the Subscription Amount set forth opposite its name on Schedule I in same-day
funds or a check payable to "David Gonzalez, Esq., as Escrow Agent for Pop N Go
Inc./Cornell Capital Partners, LP", which shall be held in escrow pursuant to
the terms of the Escrow Agreement (as hereinafter defined) and disbursed in
accordance therewith.  Notwithstanding the foregoing, a Buyer may withdraw his
Subscription Amount and terminate this Agreement as to such Buyer at any time
after the execution hereof and prior to Closing (as hereinafter defined).

        (b)	Closing Date.  The First Closing of the purchase and sale of the
Convertible Debentures shall take place at 10:00 a.m. Eastern Standard Time on
the fifth (5th) business day following the date hereof, subject to notification
of satisfaction of the conditions to the First Closing set forth herein and in
Sections 6 and 7 below (or such other date as is mutually agreed to by the
Company and the Buyer) (the "First Closing Date") and the Second Closing of the
purchase and sale of the Convertible Debentures shall take place at 10:00 a.m.
Eastern Standard Time on the date five (5) business days following the date the
Company effectuates an increase its authorized capital stock to at least
900,000,000 shares of Common Stock, subject to notification of satisfaction of
the conditions to the Second Closing set forth herein and in Sections 6 and 7
below (or such other date as is mutually agreed to by the Company and the Buyer)
(the "Second Closing Date") (collectively referred to a the "Closing Dates").
The Closing shall occur on the respective Closing Dates at the offices of
Yorkville Advisors, LLC, 3700 Hudson Street, Suite 3700, Jersey City, New Jersey
07302 (or such other place as is mutually agreed to by the Company and the
Buyer).

        (c)	Escrow Arrangements; Form of Payment.  Upon execution hereof by
the Buyer and pending the Closings, the aggregate proceeds of the sale of the
Convertible Debentures to Buyer pursuant hereto shall be deposited in a non-
interest bearing escrow account with the Escrow Agent, pursuant to the terms the
Escrow Agreement.  Subject to the satisfaction of the terms and conditions of
this Agreement, on the Closing Dates, (i) the Escrow Agent shall deliver to the
Company in accordance with the terms of the Escrow Agreement such aggregate
proceeds for the Convertible Debentures to be issued and sold to such Buyer,
minus the fees to be paid directly from the proceeds the Closings as set forth
herein, and (ii) the Company shall deliver to each Buyer, Convertible Debentures
which such Buyer is purchasing in amounts indicated opposite such Buyer's name
on Schedule I, duly executed on behalf of the Company.

    2.	BUYER'S REPRESENTATIONS AND WARRANTIES.

Each Buyer represents and warrants, severally and not jointly, that:

      (a)	Investment Purpose.  Each Buyer is acquiring the Convertible
Debentures and, upon conversion of Convertible Debentures, the Buyer will
acquire the Conversion Shares then issuable, for its own account for investment
only and not with a view towards, or for resale in connection with, the public
sale or distribution thereof, except pursuant to sales registered or exempted
under the Securities Act; provided, however, that by making the representations
herein, such Buyer reserves the right to dispose of the Conversion Shares at any
time in accordance with or pursuant to an effective registration statement
covering such Conversion Shares or an available exemption under the Securities
Act.

      (b)	Accredited Investor Status.  Each Buyer is an "Accredited
Investor" as that term is defined in Rule 501(a)(3) of Regulation D.

      (c)	Reliance on Exemptions.  Each Buyer understands that the
Convertible Debentures are being offered and sold to it in reliance on specific
exemptions from the registration requirements of United States federal and state
securities laws and that the Company is relying in part upon the truth and
accuracy of, and such Buyer's compliance with, the representations, warranties,
agreements, acknowledgments and understandings of such Buyer set forth herein in
order to determine the availability of such exemptions and the eligibility of
such Buyer to acquire such securities.

      (d)	Information.  Each Buyer and its advisors (and his or, its
counsel), if any, have been furnished with all materials relating to the
business, finances and operations of the Company and information he deemed
material to making an informed investment decision regarding his purchase of the
Convertible Debentures and the Conversion Shares, which have been requested by
such Buyer.  Each Buyer and its advisors, if any, have been afforded the
opportunity to ask questions of the Company and its management.  Neither such
inquiries nor any other due diligence investigations conducted by such Buyer or
its advisors, if any, or its representatives shall modify, amend or affect such
Buyer's right to rely on the Company's representations and warranties contained
in Section 3 below.  Each Buyer understands that its investment in the
Convertible Debentures and the Conversion Shares involves a high degree of risk.
Each Buyer is in a position regarding the Company, which, based upon employment,
family relationship or economic bargaining power, enabled and enables such Buyer
to obtain information from the Company in order to evaluate the merits and risks
of this investment.  Each Buyer has sought such accounting, legal and tax
advice, as it has considered necessary to make an informed investment decision
with respect to its acquisition of the Convertible Debentures and the Conversion
Shares.

      (e)	No Governmental Review.  Each Buyer understands that no United
States federal or state agency or any other government or governmental agency
has passed on or made any recommendation or endorsement of the Convertible
Debentures or the Conversion Shares, or the fairness or suitability of the
investment in the Convertible Debentures or the Conversion Shares, nor have such
authorities passed upon or endorsed the merits of the offering of the
Convertible Debentures or the Conversion Shares.

      (f)	Transfer or Resale.  Each Buyer understands that except as
provided in the Investor Registration Rights Agreement: (i) the Convertible
Debentures have not been and are not being registered under the Securities Act
or any state securities laws, and may not be offered for sale, sold, assigned or
transferred unless (A) subsequently registered thereunder, or (B) such Buyer
shall have delivered to the Company an opinion of counsel, in a generally
acceptable form, to the effect that such securities to be sold, assigned or
transferred may be sold, assigned or transferred pursuant to an exemption from
such registration requirements; (ii) any sale of such securities made in
reliance on Rule 144 under the Securities Act (or a successor rule thereto)
("Rule 144") may be made only in accordance with the terms of Rule 144 and
further, if Rule 144 is not applicable, any resale of such securities under
circumstances in which the seller (or the person through whom the sale is made)
may be deemed to be an underwriter (as that term is defined in the Securities
Act) may require compliance with some other exemption under the Securities Act
or the rules and regulations of the SEC thereunder; and (iii) neither the
Company nor any other person is under any obligation to register such securities
under the Securities Act or any state securities laws or to comply with the
terms and conditions of any exemption thereunder.  The Company reserves the
right to place stop transfer instructions against the shares and certificates
for the Conversion Shares.

      (g)	Legends.  Each Buyer understands that the certificates or other
instruments representing the Convertible Debentures and or the Conversion Shares
shall bear a restrictive legend in substantially the following form (and a stop
transfer order may be placed against transfer of such stock certificates):

           THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN
	   REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR
	   APPLICABLE STATE SECURITIES LAWS.  THE SECURITIES HAVE BEEN ACQUIRED
	   SOLELY FOR INVESTMENT PURPOSES AND NOT WITH A VIEW TOWARD RESALE AND
	   MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE
	   ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES
	   UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE
	   SECURITIES LAWS, OR AN OPINION OF COUNSEL, IN A GENERALLY ACCEPTABLE
	   FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR APPLICABLE
	   STATE SECURITIES LAWS.

The legend set forth above shall be removed and the Company within two (2)
business days shall issue a certificate without such legend to the holder of the
Conversion Shares upon which it is stamped, if, unless otherwise required by
state securities laws, (i) in connection with a sale transaction, provided the
Conversion Shares are registered under the Securities Act or (ii) in connection
with a sale transaction, after such holder provides the Company with an opinion
of counsel, which opinion shall be in form, substance and scope customary for
opinions of counsel in comparable transactions, to the effect that a public
sale, assignment or transfer of the Conversion Shares may be made without
registration under the Securities Act.

     (h)	Authorization, Enforcement.  This Agreement has been duly and
validly authorized, executed and delivered on behalf of such Buyer and is a
valid and binding agreement of such Buyer enforceable in accordance with its
terms, except as such enforceability may be limited by general principles of
equity or applicable bankruptcy, insolvency, reorganization, moratorium,
liquidation and other similar laws relating to, or affecting generally, the
enforcement of applicable creditors' rights and remedies.

     (i)	Receipt of Documents.  Each Buyer and his or its counsel has
received and read in their entirety:  (i) this Agreement and each
representation, warranty and covenant set forth herein, the Security Agreement,
the Investor Registration Rights Agreement, the Escrow Agreement, and the
Irrevocable Transfer Agent Agreement; (ii) all due diligence and other
information necessary to verify the accuracy and completeness of such
representations, warranties and covenants; (iii) the Company's Form 10-KSB for
the fiscal year ended December 31, 2004; (iv) the Company's Form 10-QSB for the
fiscal quarter ended July 31, 2005 and (v) answers to all questions each Buyer
submitted to the Company regarding an investment in the Company; and each Buyer
has relied on the information contained therein and has not been furnished any
other documents, literature, memorandum or prospectus.

     (j)	Due Formation of Corporate and Other Buyers.  If the Buyer is a
corporation, trust, partnership or other entity that is not an individual
person, it has been formed and validly exists and has not been organized for the
specific purpose of purchasing the Convertible Debentures and is not prohibited
from doing so.

     (k)	No Legal Advice From the Company.  Each Buyer acknowledges, that
it had the opportunity to review this Agreement and the transactions
contemplated by this Agreement with his or its own legal counsel and investment
and tax advisors.  Each Buyer is relying solely on such counsel and advisors and
not on any statements or representations of the Company or any of its
representatives or agents for legal, tax or investment advice with respect to
this investment, the transactions contemplated by this Agreement or the
securities laws of any jurisdiction.

3.	REPRESENTATIONS AND WARRANTIES OF THE COMPANY.

The Company represents and warrants to each of the Buyers that, except as set
forth in the SEC Documents (as defined herein) or on the Disclosure Schedule
attached hereto (the "Disclosure Schedule"):

    (a)	Organization and Qualification.  The Company and its subsidiaries are
corporations duly organized and validly existing in good standing under the laws
of the jurisdiction in which they are incorporated, and have the requisite
corporate power to own their properties and to carry on their business as now
being conducted.  Each of the Company and its subsidiaries is duly qualified as
a foreign corporation to do business and is in good standing in every
jurisdiction in which the nature of the business conducted by it makes such
qualification necessary, except to the extent that the failure to be so
qualified or be in good standing would not have a material adverse effect on the
Company and its subsidiaries taken as a whole.

    (b)	Authorization, Enforcement, Compliance with Other Instruments.  (i) The
Company has the requisite corporate power and authority to enter into and
perform this Agreement, the Security Agreement, the Investor Registration Rights
Agreement, the Irrevocable Transfer Agent Agreement, the Escrow Agreement, and
any related agreements (collectively the "Transaction Documents") and to issue
the Convertible Debentures and the Conversion Shares in accordance with the
terms hereof and thereof, (ii) the execution and delivery of the Transaction
Documents by the Company and the consummation by it of the transactions
contemplated hereby and thereby, including, without limitation, the issuance of
the Convertible Debentures the Conversion Shares  and the reservation for
issuance and the issuance of the Conversion Shares issuable upon conversion or
exercise thereof, have been duly authorized by the Company's Board of Directors
and no further consent or authorization is required by the Company, its Board of
Directors or its stockholders, (iii) the Transaction Documents have been duly
executed and delivered by the Company, (iv) the Transaction Documents constitute
the valid and binding obligations of the Company enforceable against the Company
in accordance with their terms, except as such enforceability may be limited by
general principles of equity or applicable bankruptcy, insolvency,
reorganization, moratorium, liquidation or similar laws relating to, or
affecting generally, the enforcement of creditors' rights and remedies.  The
authorized officer of the Company executing the Transaction Documents knows of
no reason why the Company cannot file the registration statement as required
under the Investor Registration Rights Agreement or perform any of the Company's
other obligations under such documents.

    (c)	Capitalization.  As of the date hereof the authorized capital stock of
the Company consists of 300,000,000 shares of Common Stock and zero shares of
Preferred Stock of which 122,489,060 shares of Common Stock are issued and
outstanding.  All of such outstanding shares have been validly issued and are
fully paid and nonassessable.  Except as disclosed in the SEC Documents (as
defined in Section 3(f)), no shares of Common Stock are subject to preemptive
rights or any other similar rights or any liens or encumbrances suffered or
permitted by the Company.  Except as disclosed in the SEC Documents, as of the
date of this Agreement, (i) there are no outstanding options, warrants, scrip,
rights to subscribe to, calls or commitments of any character whatsoever
relating to, or securities or rights convertible into, any shares of capital
stock of the Company or any of its subsidiaries, or contracts, commitments,
understandings or arrangements by which the Company or any of its subsidiaries
is or may become bound to issue additional shares of capital stock of the
Company or any of its subsidiaries or options, warrants, scrip, rights to
subscribe to, calls or commitments of any character whatsoever relating to, or
securities or rights convertible into, any shares of capital stock of the
Company or any of its subsidiaries, (ii) there are no outstanding debt
securities and (iii) there are no agreements or arrangements under which the
Company or any of its subsidiaries is obligated to register the sale of any of
their securities under the Securities Act (except pursuant to the Registration
Rights Agreement) and (iv) there are no outstanding registration statements and
there are no outstanding comment letters from the SEC or any other regulatory
agency.  There are no securities or instruments containing anti- dilution or
similar provisions that will be triggered by the issuance of the Convertible
Debentures as described in this Agreement.  The Company has furnished to the
Buyer true and correct copies of the Company's Articles of Incorporation, as
amended and as in effect on the date hereof (the "Articles of Incorporation"),
and the Company's By-laws, as in effect on the date hereof (the "By-laws"), and
the terms of all securities convertible into or exercisable for Common Stock and
the material rights of the holders thereof in respect thereto other than stock
options issued to employees and consultants.

    (d)	Issuance of Securities.  The Convertible Debentures are duly authorized
and, upon issuance in accordance with the terms hereof, shall be duly issued,
fully paid and nonassessable, are free from all taxes, liens and charges with
respect to the issue thereof.  The Conversion Shares issuable upon conversion of
the Convertible Debentures have been duly authorized and reserved for issuance.
Upon conversion or exercise in accordance with the Convertible Debentures the
Conversion Shares will be duly issued, fully paid and nonassessable.

    (e)	No Conflicts.  The execution, delivery and performance of the
Transaction Documents by the Company and the consummation by the Company of the
transactions contemplated hereby will not (i) result in a violation of the
Articles of Incorporation, any certificate of designations of any outstanding
series of preferred stock of the Company or the By-laws or (ii) conflict with or
constitute a default (or an event which with notice or lapse of time or both
would become a default) under, or give to others any rights of termination,
amendment, acceleration or cancellation of, any agreement, indenture or
instrument to which the Company or any of its subsidiaries is a party, or result
in a violation of any law, rule, regulation, order, judgment or decree
(including federal and state securities laws and regulations and the rules and
regulations of The National Association of Securities Dealers Inc.'s OTC
Bulletin Board on which the Common Stock is quoted) applicable to the Company or
any of its subsidiaries or by which any property or asset of the Company or any
of its subsidiaries is bound or affected.  Neither the Company nor its
subsidiaries is in violation of any term of or in default under its Articles of
Incorporation or By-laws or their organizational charter or by-laws,
respectively, or any material contract, agreement, mortgage, indebtedness,
indenture, instrument, judgment, decree or order or any statute, rule or
regulation applicable to the Company or its subsidiaries.  The business of the
Company and its subsidiaries is not being conducted, and shall not be conducted
in violation of any material law, ordinance, or regulation of any governmental
entity.  Except as specifically contemplated by this Agreement and as required
under the Securities Act and any applicable state securities laws, the Company
is not required to obtain any consent, authorization or order of, or make any
filing or registration with, any court or governmental agency in order for it to
execute, deliver or perform any of its obligations under or contemplated by this
Agreement or the Registration Rights Agreement in accordance with the terms
hereof or thereof.  All consents, authorizations, orders, filings and
registrations which the Company is required to obtain pursuant to the preceding
sentence have been obtained or effected on or prior to the date hereof.  The
Company and its subsidiaries are unaware of any facts or circumstance, which
might give rise to any of the foregoing.

    (f)	SEC Documents: Financial Statements.  Since January 1, 2003, the Company
has filed all reports, schedules, forms, statements and other documents required
to be filed by it with the SEC under the Securities Exchange Act of 1934, as
amended (the "Exchange Act") (all of the foregoing filed prior to the date
hereof or amended after the date hereof and all exhibits included therein and
financial statements and schedules thereto and documents incorporated by
reference therein, being hereinafter referred to as the "SEC Documents").  The
Company has delivered to the Buyers or their representatives, or made available
through the SEC's website at http://www.sec.gov., true and complete copies of
the SEC Documents.  As of their respective dates, the financial statements of
the Company disclosed in the SEC Documents (the "Financial Statements") complied
as to form in all material respects with applicable accounting requirements and
the published rules and regulations of the SEC with respect thereto.  Such
financial statements have been prepared in accordance with generally accepted
accounting principles, consistently applied, during the periods involved (except
(i) as may be otherwise indicated in such Financial Statements or the notes
thereto, or (ii) in the case of unaudited interim statements, to the extent they
may exclude footnotes or may be condensed or summary statements) and, fairly
present in all material respects the financial position of the Company as of the
dates thereof and the results of its operations and cash flows for the periods
then ended (subject, in the case of unaudited statements, to normal year-end
audit adjustments).  No other information provided by or on behalf of the
Company to the Buyer which is not included in the SEC Documents, including,
without limitation, information referred to in this Agreement, contains any
untrue statement of a material fact or omits to state any material fact
necessary in order to make the statements therein, in the light of the
circumstances under which they were made, not misleading.

    (g)	10(b)-5.  The SEC Documents do not include any untrue statements of
material fact, nor do they omit to state any material fact required to be stated
therein necessary to make the statements made, in light of the circumstances
under which they were made, not misleading.

    (h)	Absence of Litigation.  There is no action, suit, proceeding, inquiry or
investigation before or by any court, public board, government agency, self-
regulatory organization or body pending against or affecting the Company, the
Common Stock or any of the Company's subsidiaries, wherein an unfavorable
decision, ruling or finding would (i) have a material adverse effect on the
transactions contemplated hereby (ii) adversely affect the validity or
enforceability of, or the authority or ability of the Company to perform its
obligations under, this Agreement or any of the documents contemplated herein,
or (iii) have a material adverse effect on the business, operations, properties,
financial condition or results of operations of the Company and its subsidiaries
taken as a whole.

    (i)	Acknowledgment Regarding Buyer's Purchase of the Convertible Debentures.
The Company acknowledges and agrees that the Buyer is acting solely in the
capacity of an arm's length purchaser with respect to this Agreement and the
transactions contemplated hereby.  The Company further acknowledges that the
Buyer is not acting as a financial advisor or fiduciary of the Company (or in
any similar capacity) with respect to this Agreement and the transactions
contemplated hereby and any advice given by the Buyer or any of their respective
representatives or agents in connection with this Agreement and the transactions
contemplated hereby is merely incidental to such Buyer's purchase of the
Convertible Debentures or the Conversion Shares.  The Company further represents
to the Buyer that the Company's decision to enter into this Agreement has been
based solely on the independent evaluation by the Company and its
representatives.

    (j)	No General Solicitation.  Neither the Company, nor any of its
affiliates, nor any person acting on its or their behalf, has engaged in any
form of general solicitation or general advertising (within the meaning of
Regulation D under the Securities Act) in connection with the offer or sale of
the Convertible Debentures or the Conversion Shares.

    (k)	No Integrated Offering.  Neither the Company, nor any of its affiliates,
nor any person acting on its or their behalf has, directly or indirectly, made
any offers or sales of any security or solicited any offers to buy any security,
under circumstances that would require registration of the Convertible
Debentures or the Conversion Shares under the Securities Act or cause this
offering of the Convertible Debentures or the Conversion Shares to be integrated
with prior offerings by the Company for purposes of the Securities Act.

    (l)	Employee Relations.  Neither the Company nor any of its subsidiaries is
involved in any labor dispute nor, to the knowledge of the Company or any of its
subsidiaries, is any such dispute threatened.  None of the Company's or its
subsidiaries' employees is a member of a union and the Company and its
subsidiaries believe that their relations with their employees are good.

    (m)	Intellectual Property Rights.  The Company and its subsidiaries own or
possess adequate rights or licenses to use all trademarks, trade names, service
marks, service mark registrations, service names, patents, patent rights,
copyrights, inventions, licenses, approvals, governmental authorizations, trade
secrets and rights necessary to conduct their respective businesses as now
conducted.  The Company and its subsidiaries do not have any knowledge of any
infringement by the Company or its subsidiaries of trademark, trade name rights,
patents, patent rights, copyrights, inventions, licenses, service names, service
marks, service mark registrations, trade secret or other similar rights of
others, and, to the knowledge of the Company there is no claim, action or
proceeding being made or brought against, or to the Company's knowledge, being
threatened against, the Company or its subsidiaries regarding trademark, trade
name, patents, patent rights, invention, copyright, license, service names,
service marks, service mark registrations, trade secret or other infringement;
and the Company and its subsidiaries are unaware of any facts or circumstances
which might give rise to any of the foregoing.

    (n)	Environmental Laws.  The Company and its subsidiaries are (i) in
compliance with any and all applicable foreign, federal, state and local laws
and regulations relating to the protection of human health and safety, the
environment or hazardous or toxic substances or wastes, pollutants or
contaminants ("Environmental Laws"), (ii) have received all permits, licenses or
other approvals required of them under applicable Environmental Laws to conduct
their respective businesses and (iii) are in compliance with all terms and
conditions of any such permit, license or approval.

    (o)	Title.  Any real property and facilities held under lease by the Company
and its subsidiaries are held by them under valid, subsisting and enforceable
leases with such exceptions as are not material and do not interfere with the
use made and proposed to be made of such property and buildings by the Company
and its subsidiaries.

    (p)	Insurance.  The Company and each of its subsidiaries are insured by
insurers of recognized financial responsibility against such losses and risks
and in such amounts as management of the Company believes to be prudent and
customary in the businesses in which the Company and its subsidiaries are
engaged.  Neither the Company nor any such subsidiary has been refused any
insurance coverage sought or applied for and neither the Company nor any such
subsidiary has any reason to believe that it will not be able to renew its
existing insurance coverage as and when such coverage expires or to obtain
similar coverage from similar insurers as may be necessary to continue its
business at a cost that would not materially and adversely affect the condition,
financial or otherwise, or the earnings, business or operations of the Company
and its subsidiaries, taken as a whole.

    (q)	Regulatory Permits.  The Company and its subsidiaries possess all
material certificates, authorizations and permits issued by the appropriate
federal, state or foreign regulatory authorities necessary to conduct their
respective businesses, and neither the Company nor any such subsidiary has
received any notice of proceedings relating to the revocation or modification of
any such certificate, authorization or permit.

    (r)	Internal Accounting Controls.  The Company and each of its subsidiaries
maintain a system of internal accounting controls sufficient to provide
reasonable assurance that (i) transactions are executed in accordance with
management's general or specific authorizations, (ii) transactions are recorded
as necessary to permit preparation of financial statements in conformity with
generally accepted accounting principles and to maintain asset accountability,
and (iii) the recorded amounts for assets is compared with the existing assets
at reasonable intervals and appropriate action is taken with respect to any
differences.

    (s)	No Material Adverse Breaches, etc.  Neither the Company nor any of its
subsidiaries is subject to any charter, corporate or other legal restriction, or
any judgment, decree, order, rule or regulation which in the judgment of the
Company's officers has or is expected in the future to have a material adverse
effect on the business, properties, operations, financial condition, results of
operations or prospects of the Company or its subsidiaries.  Neither the Company
nor any of its subsidiaries is in breach of any contract or agreement which
breach, in the judgment of the Company's officers, has or is expected to have a
material adverse effect on the business, properties, operations, financial
condition, results of operations or prospects of the Company or its
subsidiaries.

    (t)	Tax Status.  The Company and each of its subsidiaries has made and filed
all federal and state income and all other tax returns, reports and declarations
required by any jurisdiction to which it is subject and (unless and only to the
extent that the Company and each of its subsidiaries has set aside on its books
provisions reasonably adequate for the payment of all unpaid and unreported
taxes) has paid all taxes and other governmental assessments and charges that
are material in amount, shown or determined to be due on such returns, reports
and declarations, except those being contested in good faith and has set aside
on its books provision reasonably adequate for the payment of all taxes for
periods subsequent to the periods to which such returns, reports or declarations
apply.  There are no unpaid taxes in any material amount claimed to be due by
the taxing authority of any jurisdiction, and the officers of the Company know
of no basis for any such claim.

    (u)	Certain Transactions.  Except for arm's length transactions pursuant to
which the Company makes payments in the ordinary course of business upon terms
no less favorable than the Company could obtain from third parties and other
than the grant of stock options disclosed in the SEC Documents, none of the
officers, directors, or employees of the Company is presently a party to any
transaction with the Company (other than for services as employees, officers and
directors), including any contract, agreement or other arrangement providing for
the furnishing of services to or by, providing for rental of real or personal
property to or from, or otherwise requiring payments to or from any officer,
director or such employee or, to the knowledge of the Company, any corporation,
partnership, trust or other entity in which any officer, director, or any such
employee has a substantial interest or is an officer, director, trustee or
partner.

    (v)	Fees and Rights of First Refusal.  The Company is not obligated to offer
the securities offered hereunder on a right of first refusal basis or otherwise
to any third parties including, but not limited to, current or former
shareholders of the Company, underwriters, brokers, agents or other third
parties.

  4.	COVENANTS.

       (a)	Best Efforts.  Each party shall use its best efforts to timely
satisfy each of the conditions to be satisfied by it as provided in Sections 6
and 7 of this Agreement.

       (b)	Form D.  The Company agrees to file a Form D with respect to the
Conversion Shares as required under Regulation D and to provide a copy thereof
to each Buyer promptly after such filing.  The Company shall, on or before the
Closing Date, take such action as the Company shall reasonably determine is
necessary to qualify the Conversion Shares, or obtain an exemption for the
Conversion Shares for sale to the Buyers at the Closing pursuant to this
Agreement under applicable securities or "Blue Sky" laws of the states of the
United States, and shall provide evidence of any such action so taken to the
Buyers on or prior to the Closing Date.

       (c)	Reporting Status.  Until the earlier of (i) the date as of which
the Buyer may sell all of the Conversion Shares without restriction pursuant to
Rule 144(k) promulgated under the Securities Act (or successor thereto), or (ii)
the date on which (A) the Buyer shall have sold all the Conversion Shares and
(B) none of the Convertible Debentures are outstanding (the "Registration
Period"), the Company shall file in a timely manner all reports required to be
filed with the SEC pursuant to the Exchange Act and the regulations of the SEC
thereunder, and the Company shall not terminate its status as an issuer required
to file reports under the Exchange Act even if the Exchange Act or the rules and
regulations thereunder would otherwise permit such termination.

       (d)	Use of Proceeds.  The Company will use the proceeds from the
sale of the Convertible Debentures for general corporate and working capital
purposes.

       (e)	Reservation of Shares.  The Company shall take all action
reasonably necessary to at all times have authorized, and reserved for the
purpose of issuance, such number of shares of Common Stock as shall be necessary
to effect the issuance of the Conversion Shares.  If at any time the Company
does not have available such shares of Common Stock as shall from time to time
be sufficient to effect the conversion of all of the Conversion Shares, the
Company shall call and hold a special meeting of the shareholders within thirty
(30) days of such occurrence, for the sole purpose of increasing the number of
shares authorized.  The Company's management shall recommend to the shareholders
to vote in favor of increasing the number of shares of Common Stock authorized.
Management shall also vote all of its shares in favor of increasing the number
of authorized shares of Common Stock.

       (f)	Listings or Quotation.  The Company shall promptly secure the
listing or quotation of the Conversion Shares upon each national securities
exchange, automated quotation system or The National Association of Securities
Dealers Inc.'s Over-The-Counter Bulletin Board ("OTCBB") or other market, if
any, upon which shares of Common Stock are then listed or quoted (subject to
official notice of issuance) and shall use its best efforts to maintain, so long
as any other shares of Common Stock shall be so listed, such listing of all
Conversion Shares from time to time issuable under the terms of this Agreement.
The Company shall maintain the Common Stock's authorization for quotation on the
OTCBB.

       (g)	Fees and Expenses.

               (i)	Each of the Company and the Buyer shall pay all costs
and expenses incurred by such party in connection with the negotiation,
investigation, preparation, execution and delivery of the Transaction Documents.
The Company shall pay Yorkville Advisors Management LLC a fee equal to $80,894,
of which $30,894 shall be paid directly from the gross proceeds of the First
Closing and $50,000 shall be paid directly from the gross proceeds of the Second
Closing.

               (ii)	The Company shall pay a structuring fee to Yorkville
Advisors Management, LLC of Ten Thousand Dollars ($10,000) which shall be paid
directly from the gross proceeds of the First Closing.

               (iii)	The Company shall issue to the Buyer a warrant to
purchase One Hundred Twenty Million (120,000,000) shares of the Common Stock
(the "Warrant Shares") for a period of five (5) years at an exercise price of
$0.01 per share.  The Warrant Shares shall have "piggy-back" and demand
registration rights.

     (h)	Corporate Existence.  So long as any of the Convertible
Debentures remain outstanding, the Company shall not directly or indirectly
consummate any merger, reorganization, restructuring, reverse stock split
consolidation, sale of all or substantially all of the Company's assets or any
similar transaction or related transactions (each such transaction, an
"Organizational Change") unless, prior to the consummation an Organizational
Change, the Company obtains the written consent of each Buyer.  In any such
case, the Company will make appropriate provision with respect to such holders'
rights and interests to insure that the provisions of this Section 4(h) will
thereafter be applicable to the Convertible Debentures.

     (i)	Transactions With Affiliates.  So long as any Convertible
Debentures are outstanding, the Company shall not, and shall cause each of its
subsidiaries not to, enter into, amend, modify or supplement, or permit any
subsidiary to enter into, amend, modify or supplement any agreement,
transaction, commitment, or arrangement with any of its or any subsidiary's
officers, directors, person who were officers or directors at any time during
the previous two (2) years, stockholders who beneficially own five percent (5%)
or more of the Common Stock, or Affiliates (as defined below) or with any
individual related by blood, marriage, or adoption to any such individual or
with any entity in which any such entity or individual owns a five percent (5%)
or more beneficial interest (each a "Related Party"), except for (a) customary
employment arrangements and benefit programs on reasonable terms, (b) any
investment in an Affiliate of the Company,  (c) any agreement, transaction,
commitment, or arrangement on an arms-length basis on terms no less favorable
than terms which would have been obtainable from a person other than such
Related Party, (d) any agreement, transaction, commitment, or arrangement which
is approved by a majority of the disinterested directors of the Company; for
purposes hereof, any director who is also an officer of the Company or any
subsidiary of the Company shall not be a disinterested director with respect to
any such agreement, transaction, commitment, or arrangement.  "Affiliate" for
purposes hereof means, with respect to any person or entity, another person or
entity that, directly or indirectly, (i) has a ten percent (10%) or more equity
interest in that person or entity, (ii) has ten percent (10%) or more common
ownership with that person or entity, (iii) controls that person or entity, or
(iv) shares common control with that person or entity. "Control" or "controls"
for purposes hereof means that a person or entity has the power, direct or
indirect, to conduct or govern the policies of another person or entity.

     (j)	Transfer Agent.  The Company covenants and agrees that, in the
event that the Company's agency relationship with the transfer agent should be
terminated for any reason prior to a date which is two (2) years after the
Closing Date, the Company shall immediately appoint a new transfer agent and
shall require that the new transfer agent execute and agree to be bound by the
terms of the Irrevocable Transfer Agent Instructions (as defined herein).

     (k)	Restriction on Issuance of the Capital Stock. So long as any
Convertible Debentures are outstanding, the Company shall not, without the prior
written consent of the Buyer, (i) issue or sell shares of Common Stock or
Preferred Stock without consideration or for a consideration per share less than
the bid price of the Common Stock determined immediately prior to its issuance,
(ii) issue any preferred stock, warrant, option, right, contract, call, or other
security or instrument granting the holder thereof the right to acquire Common
Stock without consideration or for a consideration less than such Common Stock's
Bid Price determined immediately prior to it's issuance, (iii) enter into any
security instrument granting the holder a security interest in any and all
assets of the Company, or (iv) file any registration statement on Form S-8.

     (l)	Neither the Buyer nor any of its affiliates have an open short
position in the Common Stock of the Company, and the Buyer agrees that it shall
not, and that it will cause its affiliates not to, engage in any short sales of
or hedging transactions with respect to the Common Stock as long as any
Convertible Debentures shall remain outstanding.

     (m)	Rights of First Refusal.  For a period of 18 months from the
date hereof, if the Company intends to raise aver $100,000 of additional capital
by the issuance or sale of capital stock of the Company, including without
limitation shares of any class of common stock, any class of preferred stock,
options, warrants or any other securities convertible or exercisable into shares
of common stock (whether the offering is conducted by the Company, underwriter,
placement agent or any third party) the Company shall be obligated to offer to
the Buyers such issuance or sale of capital stock, by providing in writing the
principal amount of capital it intends to raise and outline of the material
terms of such capital raise, prior to the offering such issuance or sale of
capital stock  to any third parties including, but not limited to, current or
former officers or directors, current or former shareholders and/or investors of
the obligor, underwriters, brokers, agents or other third parties.  The Buyers
shall have five (5) business days from receipt of such notice of the sale or
issuance of capital stock to accept or reject all or a portion of such capital
raising offer.

     (n)	Increase Authorized.	The Company shall, within 75 days of the
date hereof, effectuate an increase its authorized capital stock to at least
900,000,000 shares of Common Stock.

     5.	TRANSFER AGENT INSTRUCTIONS.

       (a)	The Company shall issue the Irrevocable Transfer Agent
Instructions to its transfer agent irrevocably appointing David Gonzalez, Esq.
as the Company's agent for purpose of having certificates issued, registered in
the name of the Buyer or its respective nominee(s), for the Conversion Shares
representing such amounts of Convertible Debentures as specified from time to
time by the Buyer to the Company upon conversion of the Convertible Debentures,
for interest owed pursuant to the Convertible Debenture, and for any and all
Liquidated Damages (as this term is defined in the Investor Registration Rights
Agreement).  David Gonzalez, Esq. shall be paid a cash fee of Fifty Dollars
($50) for every occasion they act pursuant to the Irrevocable Transfer Agent
Instructions.  The Company shall not change its transfer agent without the
express written consent of the Buyer, which may be withheld by the Buyer in its
sole discretion.  Prior to registration of the Conversion Shares under the
Securities Act, all such certificates shall bear the restrictive legend
specified in Section 2(g) of this Agreement.  The Company warrants that no
instruction other than the Irrevocable Transfer Agent Instructions referred to
in this Section 5, and stop transfer instructions to give effect to Section 2(g)
hereof (in the case of the Conversion Shares prior to registration of such
shares under the Securities Act) will be given by the Company to its transfer
agent and that the Conversion Shares shall otherwise be freely transferable on
the books and records of the Company as and to the extent provided in this
Agreement and the Investor Registration Rights Agreement.  Nothing in this
Section 5 shall affect in any way the Buyer's obligations and agreement to
comply with all applicable securities laws upon resale of Conversion Shares.  If
the Buyer provides the Company with an opinion of counsel, in form, scope and
substance customary for opinions of counsel in comparable transactions to the
effect that registration of a resale by the Buyer of any of the Conversion
Shares is not required under the Securities Act, the Company shall within two
(2) business days instruct its transfer agent to issue one or more certificates
in such name and in such denominations as specified by the Buyer.  The Company
acknowledges that a breach by it of its obligations hereunder will cause
irreparable harm to the Buyer by vitiating the intent and purpose of the
transaction contemplated hereby.  Accordingly, the Company acknowledges that the
remedy at law for a breach of its obligations under this Section 5 will be
inadequate and agrees, in the event of a breach or threatened breach by the
Company of the provisions of this Section 5, that the Buyer shall be entitled,
in addition to all other available remedies, to an injunction restraining any
breach and requiring immediate issuance and transfer, without the necessity of
showing economic loss and without any bond or other security being required.

    6.	CONDITIONS TO THE COMPANY'S OBLIGATION TO SELL.

The obligation of the Company hereunder to issue and sell the Convertible
Debentures to the Buyer at the Closings is subject to the satisfaction, at or
before the Closing Dates, of each of the following conditions, provided that
these conditions are for the Company's sole benefit and may be waived by the
Company at any time in its sole discretion:

      (a)	Each Buyer shall have executed the Transaction Documents and
delivered them to the Company.

      (b)	The Buyer shall have delivered to the Escrow Agent the Purchase
Price for Convertible Debentures in respective amounts as set forth next to each
Buyer as outlined on Schedule I attached hereto and the Escrow Agent shall have
delivered the net proceeds to the Company by wire transfer of immediately
available U.S. funds pursuant to the wire instructions provided by the Company.

      (c)	The representations and warranties of the Buyer shall be true
and correct in all material respects as of the date when made and as of the
Closing Dates as though made at that time (except for representations and
warranties that speak as of a specific date), and the Buyer shall have
performed, satisfied and complied in all material respects with the covenants,
agreements and conditions required by this Agreement to be performed, satisfied
or complied with by the Buyer at or prior to the Closing Dates. 7.
CONDITIONS TO THE BUYER'S OBLIGATION TO PURCHASE.

      (a)	The obligation of the Buyer hereunder to purchase the
Convertible Debentures at the First Closing is subject to the satisfaction, at
or before the First Closing Date, of each of the following conditions:

                (i)	The Company shall have executed the Transaction
Documents and delivered the same to the Buyer.

                (ii)	The Common Stock shall be authorized for quotation on
the OTCBB, trading in the Common Stock shall not have been suspended for any
reason, and all the Conversion Shares issuable upon the conversion of the
Convertible Debentures shall be approved by the OTCBB.

                (iii)	The representations and warranties of the Company shall
be true and correct in all material respects (except to the extent that any of
such representations and warranties is already qualified as to materiality in
Section 3 above, in which case, such representations and warranties shall be
true and correct without further qualification) as of the date when made and as
of the First Closing Date as though made at that time (except for
representations and warranties that speak as of a specific date) and the Company
shall have performed, satisfied and complied in all material respects with the
covenants, agreements and conditions required by this Agreement to be performed,
satisfied or complied with by the Company at or prior to the First Closing Date.
If requested by the Buyer, the Buyer shall have received a certificate, executed
by the President of the Company, dated as of the First Closing Date, to the
foregoing effect and as to such other matters as may be reasonably requested by
the Buyer including, without limitation an update as of the First Closing Date
regarding the representation contained in Section 3(c) above.

                (iv)	The Company shall have executed and delivered to the
Buyer the Convertible Debentures in the respective amounts set forth opposite
each Buyer name on Schedule I attached hereto.

                (v)	The Buyer shall have received an opinion of counsel from
the Company's counsel in a form satisfactory to the Buyer.

                (vi)	The Company shall have provided to the Buyer a
certificate of good standing from the secretary of state from the state in which
the company is incorporated.

                (vii)	The Company shall have filed a form UCC-1 or such other
forms as may be required to perfect the Buyer's interest in the Pledged Property
as detailed in the Security Agreement dated the date hereof and provided proof
of such filing to the Buyer.

                (viii)	The Company shall have provided to the Buyer an
acknowledgement, to the satisfaction of the Buyer, from the Company's
independent certified public accountants as to its ability to provide all
consents required in order to file a registration statement in connection with
this transaction.

                (ix)	The Company shall have reserved out of its authorized
and unissued Common Stock, solely for the purpose of effecting the conversion of
the Convertible Debentures, shares of Common Stock to effect the conversion of
all of the Conversion Shares then outstanding.

                (x)	The Irrevocable Transfer Agent Instructions, in form and
substance satisfactory to the Buyer, shall have been delivered to and
acknowledged in writing by the Company's transfer agent.

      (b)       The obligation of the Buyer hereunder to accept the Convertible
Debentures at the Second Closing is subject to the satisfaction, at or before
the Second Closing Date, of each of the following conditions:

                (i)	The Common Stock shall be authorized for quotation on
the OTCBB, trading in the Common Stock shall not have been suspended for any
reason, and all the Conversion Shares issuable upon the conversion of the
Convertible Debentures shall be approved by the OTCBB.

                (ii)	The representations and warranties of the Company shall
be true and correct in all material respects (except to the extent that any of
such representations and warranties is already qualified as to materiality in
Section 3 above, in which case, such representations and warranties shall be
true and correct without further qualification) as of the date when made and as
of the Second Closing Date as though made at that time (except for
representations and warranties that speak as of a specific date) and the Company
shall have performed, satisfied and complied in all material respects with the
covenants, agreements and conditions required by this Agreement to be performed,
satisfied or complied with by the Company at or prior to the Second Closing
Date.  If requested by the Buyer, the Buyer shall have received a certificate,
executed by two officers of the Company, dated as of the Second Closing Date, to
the foregoing effect and as to such other matters as may be reasonably requested
by the Buyer including, without limitation an update as of the Second Closing
Date regarding the representation contained in Section 3(c) above.

                (iii)	The Company shall have executed and delivered to the
Buyer the Convertible Debentures in the respective amounts set forth opposite
each Buyer name on Schedule I attached hereto.

                (iv)	The Company shall have obtained shareholder approval and
filed its certificate of amendment to its certificate of incorporation
increasing its authorized Common Stock to at least 900,000,000 in accordance
with applicable laws.

                (v)	The Company shall have reserved with its transfer agent
out of its authorized and unissued Common Stock, solely for the purpose of
effecting the conversion of the Convertible Debentures, a minimum of 350,000,000
shares of Common Stock to effect the conversion of all of the Conversion Shares
then outstanding.

    8.	INDEMNIFICATION.

       (a)	In consideration of the Buyer's execution and delivery of this
Agreement and acquiring the Convertible Debentures and the Conversion Shares
hereunder, and in addition to all of the Company's other obligations under this
Agreement, the Company shall defend, protect, indemnify and hold harmless the
Buyer and each other holder of the Convertible Debentures and the Conversion
Shares, and all of their officers, directors, employees and agents (including,
without limitation, those retained in connection with the transactions
contemplated by this Agreement) (collectively, the "Buyer Indemnitees") from and
against any and all actions, causes of action, suits, claims, losses, costs,
penalties, fees, liabilities and damages, and expenses in connection therewith
(irrespective of whether any such Buyer Indemnitee is a party to the action for
which indemnification hereunder is sought), and including reasonable attorneys'
fees and disbursements (the "Indemnified Liabilities"), incurred by the Buyer
Indemnitees or any of them as a result of, or arising out of, or relating to (a)
any misrepresentation or breach of any representation or warranty made by the
Company in this Agreement, the Convertible Debentures or the Investor
Registration Rights Agreement or any other certificate, instrument or document
contemplated hereby or thereby, (b) any breach of any covenant, agreement or
obligation of the Company contained in this Agreement, or the Investor
Registration Rights Agreement or any other certificate, instrument or document
contemplated hereby or thereby, or (c) any cause of action, suit or claim
brought or made against such Indemnitee and arising out of or resulting from the
execution, delivery, performance or enforcement of this Agreement or any other
instrument, document or agreement executed pursuant hereto by any of the parties
hereto, any transaction financed or to be financed in whole or in part, directly
or indirectly, with the proceeds of the issuance of the Convertible Debentures
or the status of the Buyer or holder of the Convertible Debentures  the
Conversion Shares, as a Buyer of Convertible Debentures in the Company.  To the
extent that the foregoing undertaking by the Company may be unenforceable for
any reason, the Company shall make the maximum contribution to the payment and
satisfaction of each of the Indemnified Liabilities, which is permissible under
applicable law.

       (b)	In consideration of the Company's execution and delivery of this
Agreement, and in addition to all of the Buyer's other obligations under this
Agreement, the Buyer shall defend, protect, indemnify and hold harmless the
Company and all of its officers, directors, employees and agents (including,
without limitation, those retained in connection with the transactions
contemplated by this Agreement) (collectively, the "Company Indemnitees") from
and against any and all Indemnified Liabilities incurred by the Indemnitees or
any of them as a result of, or arising out of, or relating to (a) any
misrepresentation or breach of any representation or warranty made by the Buyer
in this Agreement, instrument or document contemplated hereby or thereby
executed by the Buyer, (b) any breach of any covenant, agreement or obligation
of the Buyer contained in this Agreement,  the Investor Registration Rights
Agreement or any other certificate, instrument or document contemplated hereby
or thereby executed by the Buyer, or (c) any cause of action, suit or claim
brought or made against such Company Indemnitee based on material
misrepresentations or due to a material breach and arising out of or resulting
from the execution, delivery, performance or enforcement of this Agreement, the
Investor Registration Rights Agreement or any other instrument, document or
agreement executed pursuant hereto by any of the parties hereto.  To the extent
that the foregoing undertaking by each Buyer may be unenforceable for any
reason, each Buyer shall make the maximum contribution to the payment and
satisfaction of each of the Indemnified Liabilities, which is permissible under
applicable law.

    9.	GOVERNING LAW: MISCELLANEOUS.

       (a)	Governing Law.  This Agreement shall be governed by and
interpreted in accordance with the laws of the State of New Jersey without
regard to the principles of conflict of laws.  The parties further agree that
any action between them shall be heard in Hudson County, New Jersey, and
expressly consent to the jurisdiction and venue of the Superior Court of New
Jersey, sitting in Hudson County and the United States District Court for the
District of New Jersey sitting in Newark, New Jersey for the adjudication of any
civil action asserted pursuant to this Paragraph.

       (b)	Counterparts.  This Agreement may be executed in two or more
identical counterparts, all of which shall be considered one and the same
agreement and shall become effective when counterparts have been signed by each
party and delivered to the other party.  In the event any signature page is
delivered by facsimile transmission, the party using such means of delivery
shall cause four (4) additional original executed signature pages to be
physically delivered to the other party within five (5) days of the execution
and delivery hereof.

       (c)	Headings.  The headings of this Agreement are for convenience of
reference and shall not form part of, or affect the interpretation of, this
Agreement.

       (d)	Severability.  If any provision of this Agreement shall be
invalid or unenforceable in any jurisdiction, such invalidity or
unenforceability shall not affect the validity or enforceability of the
remainder of this Agreement in that jurisdiction or the validity or
enforceability of any provision of this Agreement in any other jurisdiction.

       (e)	Entire Agreement, Amendments.  This Agreement supersedes all
other prior oral or written agreements between the Buyer, the Company, their
affiliates and persons acting on their behalf with respect to the matters
discussed herein, and this Agreement and the instruments referenced herein
contain the entire understanding of the parties with respect to the matters
covered herein and therein and, except as specifically set forth herein or
therein, neither the Company nor any Buyer makes any representation, warranty,
covenant or undertaking with respect to such matters.  No provision of this
Agreement may be waived or amended other than by an instrument in writing signed
by the party to be charged with enforcement.

       (f)	Notices.  Any notices, consents, waivers, or other
communications required or permitted to be given under the terms of this
Agreement must be in writing and will be deemed to have been delivered (i) upon
receipt, when delivered personally; (ii) upon confirmation of receipt, when sent
by facsimile; (iii) three (3) days after being sent by U.S. certified mail,
return receipt requested, or (iv) one (1) day after deposit with a nationally
recognized overnight delivery service, in each case properly addressed to the
party to receive the same.  The addresses and facsimile numbers for such
communications shall be:

If to the Company, to:	Pop N Go Inc.
	12429 East Putman Street
	Whittier, California 90602
	Attention:	Mel Wyman
	Telephone:	(562) 945-9351
	Facsimile:	(562) 945-6341

With a copy to:	Kirkpatrick & Lockhart Nicholson Graham LLP
	201 S. Biscayne Blvd. - Suite 2000
	Miami, Florida 33131
	Attention:	Clayton E. Parker, Esq.
	Telephone:	(305) 539-3306
	Facsimile:	(305) 358-7095

If to the Buyer, to its address and facsimile number on Schedule I, with copies
to the Buyer's counsel as set forth on Schedule I.  Each party shall provide
five (5) days' prior written notice to the other party of any change in address
or facsimile number.

       (g)	Successors and Assigns.  This Agreement shall be binding upon
and inure to the benefit of the parties and their respective successors and
assigns.  Neither the Company nor any Buyer shall assign this Agreement or any
rights or obligations hereunder without the prior written consent of the other
party hereto.

       (h)	No Third Party Beneficiaries.  This Agreement is intended for
the benefit of the parties hereto and their respective permitted successors and
assigns, and is not for the benefit of, nor may any provision hereof be enforced
by, any other person.

       (i)	Survival.  Unless this Agreement is terminated under Section
9(l), the representations and warranties of the Company and the Buyer contained
in Sections 2 and 3, the agreements and covenants set forth in Sections 4, 5 and
9, and the indemnification provisions set forth in Section 8, shall survive the
Closing for a period of two (2) years following the date on which the
Convertible Debentures are converted in full.  The Buyer shall be responsible
only for its own representations, warranties, agreements and covenants
hereunder.

       (j)	Publicity.  The Company and the Buyer shall have the right to
approve, before issuance any press release or any other public statement with
respect to the transactions contemplated hereby made by any party; provided,
however, that the Company shall be entitled, without the prior approval of the
Buyer, to issue any press release or other public disclosure with respect to
such transactions required under applicable securities or other laws or
regulations (the Company shall use its best efforts to consult the Buyer in
connection with any such press release or other public disclosure prior to its
release and Buyer shall be provided with a copy thereof upon release thereof).

       (k)	Further Assurances.  Each party shall do and perform, or cause
to be done and performed, all such further acts and things, and shall execute
and deliver all such other agreements, certificates, instruments and documents,
as the other party may reasonably request in order to carry out the intent and
accomplish the purposes of this Agreement and the consummation of the
transactions contemplated hereby.

       (l)	Termination.  In the event that the Closing shall not have
occurred with respect to the Buyers on or before five (5) business days from the
date hereof due to the Company's or the Buyer's failure to satisfy the
conditions set forth in Sections 6 and 7 above (and the non- breaching party's
failure to waive such unsatisfied condition(s)), the non-breaching party shall
have the option to terminate this Agreement with respect to such breaching party
at the close of business on such date without liability of any party to any
other party; provided, however, that if this Agreement is terminated by the
Company pursuant to this Section 9(l), the Company shall remain obligated to
reimburse the Buyer for the fees and expenses of Yorkville Advisors Management,
LLC described in Section 4(g) above.

       (m)	No Strict Construction.  The language used in this Agreement
will be deemed to be the language chosen by the parties to express their mutual
intent, and no rules of strict construction will be applied against any party.

[REMAINDER PAGE INTENTIONALLY LEFT BLANK]

IN WITNESS WHEREOF, the Buyers and the Company have caused this Securities
Purchase Agreement to be duly executed as of the date first written above.

	COMPANY:
	POP N GO INC.

	By:/s/
	Name:	Melvin Wyman
	Title:	Chief Executive Officer

                                   SCHEDULE I

                               SCHEDULE OF BUYERS

Name	Signature	Address/Facsimile
Number of Buyer	Subscription Amount

	/s/
Cornell Capital Partners, LP
        By:	Yorkville Advisors, LLC	101 Hudson Street - Suite 3700	$1,200,000
	Its:	General Partner	Jersey City, NJ  07303
		Facsimile:	(201) 985-8266

	By:/s/
	Name:	Mark Angelo
	Its:	Portfolio Manager

With a copy to: David Gonzalez, Esq.
                101 Hudson Street - Suite 3700
		Jersey City, NJ 07302
		Facsimile:           (201) 985-8266

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00094-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00094-of-00352.parquet"}]]